Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRASG12D Gene Dosage Drives Pancreatic Tumor Evolution and Progression.

Cancer discovery - 1 Mar 2018

Abstract excerpt

Allelic imbalance with increased KrasG12D gene dosage drives key PDAC characteristics.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Gene Dosage
Share to Pancreatic Neoplasms
Share to Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 29420182
DOI: 10.1158/2159-8290.CD-RW2018-020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRASG12D Gene Dosage Drives Pancreatic Tumor Evolution and Progression.PMID 29420182Read ↗

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalSemantic proximity Read ↗

Allelic Ratio of KRAS Mutations in Pancreatic CancerSemantic proximity Read ↗

Drivers of Gene Expression Dysregulation in Pancreatic Cancer.Semantic proximity Read ↗

The KRAS mutational spectrum and its clinical implications in pancreatic cancer.Semantic proximity Read ↗

Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe.Semantic proximity Read ↗

Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.Semantic proximity Read ↗

The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.Semantic proximity Read ↗

A disease model resource reveals core principles of tissue-specific cancer evolution.Semantic proximity Read ↗

Pancreatic Cells Are Resistant to KRASQ61L Expression due to Hyperactive ERK/MAPK Signaling and Apoptosis Induction.Semantic proximity Read ↗

KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas.Semantic proximity Read ↗

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.